![Diabetes: Neuer Wirkstoff reduziert Folgeschäden - einBLICK - Online-Magazin der Universität Würzburg Diabetes: Neuer Wirkstoff reduziert Folgeschäden - einBLICK - Online-Magazin der Universität Würzburg](https://www.uni-wuerzburg.de/fileadmin/_processed_/4/1/csm_24diabetes-studie_d95ed62f3a.jpg)
Diabetes: Neuer Wirkstoff reduziert Folgeschäden - einBLICK - Online-Magazin der Universität Würzburg
![Blut-Hirn-Schranken-hCMEC/D3-Zelllinie The hCMEC/D3 BBB cell line has been extensively characterized for brain endothelial phenotype and is a model of human blood-brain barrier (BBB) function. | Sigma-Aldrich Blut-Hirn-Schranken-hCMEC/D3-Zelllinie The hCMEC/D3 BBB cell line has been extensively characterized for brain endothelial phenotype and is a model of human blood-brain barrier (BBB) function. | Sigma-Aldrich](https://www.sigmaaldrich.com/deepweb/content/dam/sigma-aldrich/product5/102/scc066_hcmecd3_human_bbb_cell_line_scc066_hcmecd3_human_bbb_cell_line_all.jpg/_jcr_content/renditions/scc066_hcmecd3_human_bbb_cell_line_scc066_hcmecd3_human_bbb_cell_line_all-large.jpg)
Blut-Hirn-Schranken-hCMEC/D3-Zelllinie The hCMEC/D3 BBB cell line has been extensively characterized for brain endothelial phenotype and is a model of human blood-brain barrier (BBB) function. | Sigma-Aldrich
![DE69938293T2 - LUCIFERASE, GFP FLUORESCENCE PROTEINS, CODING NUCLEIC CAUSE, AND ITS USE IN DIAGNOSIS - Google Patents DE69938293T2 - LUCIFERASE, GFP FLUORESCENCE PROTEINS, CODING NUCLEIC CAUSE, AND ITS USE IN DIAGNOSIS - Google Patents](https://patentimages.storage.googleapis.com/f7/24/e3/8f3503d0a09e35/02240001.png)